Similarly, another investigation by Masliah et al., showed that nuclear DNMT1 levels were reduced in PD brain samples and SNCA transgenic mouse models, leading to insufficient DNA methylation in the CpG island upstream of the SNCA, SEPW1, and PRKAR2A genes [96]. The gene discussed is DNMT1; the disease is Parkinson disease.